Improved 10-year outcomes for prostate cancer patients with Gleason 7-10 treated with high-dose-rate brachytherapy boost in the PSA era
To access this article, please choose from the options below
PII: S1538-4721(08)00396-6
doi:10.1016/j.brachy.2008.02.340
© 2008 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.
